Conference
47 POSTER A phase II study of Sorafenib (BAY 43-9006) in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) and nasopharyngeal cancer (NPC): final results
Authors
Elser C; Siu L; Winquist E; Agulnik M; Pond G; Chin S; Francis P; Cheiken R; Petrenciuc O; Chen E
Volume
4
Publisher
Elsevier
Publication Date
November 1, 2006
DOI
10.1016/s1359-6349(06)70053-2
Conference proceedings
European Journal of Cancer Supplements
Issue
12
ISSN
1359-6349